查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942491

2026年全球乳癌篩檢測試市場報告

Breast Cancer Screening Test Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

乳癌検診市場規模は近年、著しい成長を遂げております。2025年の24億9,000万米ドルから2026年には26億9,000万米ドルへと、CAGR8.3％で拡大が見込まれております。過去数年間の成長は、乳癌発症率への認知の高まり、乳房X光攝影検診プログラムの広範な導入、診断検査インフラの拡充、標準化された検診ガイドラインの整備、公衆衛生検診施策の拡大などが要因として挙げられます。

乳癌検診検査市場規模は今後数年間で力強い成長が見込まれます。2030年には36億8,000万米ドルに達し、CAGRは8.1％となる見込みです。予測期間における成長は、個別化がん検診通訊協定の採用増加、AI搭載診断ツールの利用拡大、遺伝子検査導入の拡大、早期がん検出への注目の高まり、予防腫瘍学サービスへの投資増加に起因すると考えられます。予測期間の主な動向としては、高度な画像診断ベースの篩檢検査の採用増加、遺伝子,分子診断の利用拡大、画像解釈におけるAI統合の進展、多模態篩檢手法の拡大、早期,予防診断への注目の強化が挙げられます。

The increasing incidence of 乳癌 is expected to drive the growth of the 乳癌 cancer screening market. 乳癌 involves the abnormal and uncontrolled growth of cells in breast tissue, which can develop inich canun​​yal thes in sun​​hed sek, s​​an can deconnect in s​​stal's in s​​stal the s​​stal the s​​d the sper​​als in the soc​​als in soc​​al's in s​​an can deals in乳癌。 cancer cases is due to the aging global population, which significantly increases the risk of developing the disease, and longer life expectancies put more individuals at risk. 乳癌 screening is , for tecning isting sat form​​ly 論文 5 月 is improve treatment outcomes and reduce mortality. For example, in March 2025, Breastcancer.org, a US-based non-profit organization, predicted that approximately 316,950 women will be diagnosed with invasive 乳癌 in 2025, and an additional 59,080 new cases of ductal 乳癌，其中5500人將死於乳腺癌。在此背景下，乳癌發生率的上升是乳癌篩檢市場擴張的原因之一。

乳癌検診テスト分野の主要企業は、アクセスの向上、早期発見の促進、医療サービスが行き届いていない地域や遠隔地へのサービス拡大を目的として、移動式検診ユニットなどの先進的なソリューションの開発を優先しています。これらの移動式ユニットは、マンモグラフィーなどの画像診断技術を備えた可攜式施設であり、十分な医療アクセスが得られない地域で現地での乳癌検診を提供するために設計されています。例えば、2024年9月には、インドに本拠を置く製薬会社であるGranules India Ltd.が、恵まれないコミュニティにおける乳癌検診を促進するため、「Breast Health Express」を導入しました。このユニットは、高度なマンモグラフィーおよび超音波システムを装備しており、移動しながら質の高い検診を可能にします。この取り組みは、農村部や医療サービスが行き届いていない地域に早期発見サービスをもたらし、これらの地域の女性たちが重要な医療サービスを受けられるよう支援することを目的としています。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球乳癌篩檢市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 擴大基於先進診斷影像技術的篩檢檢測方法的應用範圍
    • 基因和分子診斷技術的廣泛應用
    • 人工智慧在影像分析中的整合進展
    • 擴展多模態篩檢方法
    • 人們越來越關注早期和預防性診斷

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷中心
  • 癌症研究所
  • 研究所
  • 專科腫瘤診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球乳癌篩檢測試市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球乳癌篩檢市場規模、比較及成長率分析
  • 全球乳癌篩檢測試市場表現：規模與成長，2020-2025年
  • 全球乳癌篩檢市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 按診斷測試類型
  • 血液標記檢測、影像檢查、基因檢測、免疫組織化學檢測
  • 按風險等級
  • 高風險族群、中風險族群和平均風險族群
  • 最終用戶
  • 醫院、診斷中心、癌症研究所、研究實驗室
  • 按類型細分：血液標記檢測
  • 循環性腫瘤細胞（CTC）檢測、基因表現檢測、循環腫瘤DNA（ctDNA）檢測、蛋白質體學生物標記檢測
  • 按類型細分：影像檢查
  • 乳房X光攝影、磁振造影篩檢、分子乳房影像、正子斷層掃描和超音波
  • 按類型細分：基因檢測
  • 螢光原位雜合反應，HER基因檢測
  • 按類型細分：免疫組織化學
  • 雌激素受體 (ER) 檢測、Ki-67 增殖標記檢測、黃體素受體 (PR) 檢測、HER2 或 Neu 檢測

第10章 區域與國家分析

  • 全球乳癌篩檢市場：依地區分類，結果及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球乳癌篩檢市場：依國家分類，結果及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章 イタリア市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 乳癌篩檢測試市場：競爭格局與市場佔有率，2024 年
  • 乳癌篩檢測試市場：公司估值矩陣
  • 乳癌篩檢測試市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Siemens Healthcare GmbH
    • Fujifilm Corporation

第37章：其他領先和創新企業

  • Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD（Becton, Dickinson and Company）, Agilent Technologies Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年乳癌篩檢市場：提供新機會的國家
  • 2030年乳癌篩檢市場：新興細分市場機會
  • 2030年乳癌篩檢市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MBCST01_G26Q1

A breast cancer screening test is a medical procedure or diagnostic method designed to detect breast cancer at an early stage, often before any symptoms develop. The main objective of screening is to discover cancer when it is most treatable, thereby potentially lowering mortality rates and enhancing patient outcomes. Early diagnosis through breast cancer screening enables timely treatment and leads to a more favorable prognosis.

The primary types of diagnostic tests used in breast cancer screening include blood marker tests, imaging tests, genetic tests, and immunohistochemistry tests. Blood marker tests identify and quantify specific substances in the blood to support disease detection, monitoring, or risk evaluation. Different levels of risk-high-risk, moderate-risk, and average-risk populations-are considered, and the tests are utilized by various end users, including hospitals, diagnostic centers, cancer institutes, and research laboratories.

Tariffs are influencing the breast cancer screening test market by increasing costs of imported imaging equipment, diagnostic reagents, genetic testing kits, and advanced laboratory instruments. Diagnostic centers and hospitals in North America and Europe are most affected due to dependence on imported imaging systems and consumables, while Asia-Pacific faces higher costs for test kit manufacturing and exports. These tariffs are increasing screening service costs and slowing equipment upgrades. However, they are also supporting local manufacturing of diagnostic kits, regional laboratory expansion, and domestic development of screening technologies.

The breast cancer screening test market research report is one of a series of new reports from The Business Research Company that provides breast cancer screening test market statistics, including breast cancer screening test industry global market size, regional shares, competitors with a breast cancer screening test market share, detailed breast cancer screening test market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer screening test industry. This breast cancer screening test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast cancer screening test market size has grown strongly in recent years. It will grow from $2.49 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing breast cancer incidence awareness, widespread deployment of mammography screening programs, expansion of diagnostic laboratory infrastructure, availability of standardized screening guidelines, growing public health screening initiatives.

The breast cancer screening test market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising adoption of personalized cancer screening protocols, increasing use of ai-powered diagnostic tools, expansion of genetic testing adoption, growing focus on early-stage cancer detection, increasing investments in preventive oncology services. Major trends in the forecast period include increasing adoption of advanced imaging-based screening tests, rising use of genetic and molecular diagnostics, growing integration of ai in image interpretation, expansion of multi-modal screening approaches, enhanced focus on early and preventive diagnostics.

The increasing incidence of breast cancer is anticipated to drive the growth of the breast cancer screening test market. Breast cancer involves the abnormal and uncontrolled growth of cells in breast tissue, which can develop into a tumor and potentially spread to other body parts. The rise in breast cancer cases is attributed to the aging global population, as older age significantly raises the risk of developing the disease, and longer life expectancies mean a greater number of individuals are at risk. Screening tests for breast cancer are essential for identifying the disease in its early stages, thereby improving treatment outcomes and lowering mortality rates. For example, in March 2025, Breastcancer.org, a nonprofit organization based in the US, projected that approximately 316,950 women would be diagnosed with invasive breast cancer in 2025, along with 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Additionally, in December 2024, the Public Health Agency of Canada reported that an estimated 28,600 women in Canada were expected to be diagnosed with breast cancer in 2022, with 5,500 fatalities anticipated. As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast cancer screening test market.

Leading companies in the breast cancer screening test sector are prioritizing the development of cutting-edge solutions such as mobile screening units to improve accessibility, increase early detection, and extend services to underserved or remote regions. These mobile units are transportable facilities equipped with diagnostic imaging technologies like mammography, designed to deliver on-site breast cancer screening in areas lacking adequate healthcare access. For instance, in September 2024, Granules India Ltd., a pharmaceutical company based in India, introduced the Breast Health Express to promote breast cancer screening in disadvantaged communities. Outfitted with advanced mammography and ultrasound systems, the unit facilitates quality screenings while on the move. This initiative aims to bring early detection services to rural and underserved areas, helping to ensure access to critical healthcare for women in these regions.

In August 2024, Hitachi High-Tech Corporation, a Japan-based producer of electronic and electrical equipment, entered into a strategic alliance with Gencurix Inc. for an undisclosed amount. Through this collaboration, Hitachi seeks to utilize its knowledge in in vitro diagnostics and digital technologies to create accurate and efficient molecular diagnostics for cancer. Gencurix Inc., headquartered in South Korea, specializes in breast cancer testing solutions.

Major companies operating in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD (Becton Dickinson and Company), Agilent Technologies Inc.

North America was the largest region in the breast cancer screening test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer screening test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the breast cancer screening test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The breast cancer screening test market consists of revenues earned by entities by providing services such as early detection, risk assessment, and tumor detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast cancer screening test market also consists of sales of products including ultrasound equipment, screening software, and breast self-examination kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Cancer Screening Test Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses breast cancer screening test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast cancer screening test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast cancer screening test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Diagnostic Test Type: Blood Marker Test; Imaging Test; Genetic Test; Immunohistochemistry Test
  • 2) By Risk Level: High-risk Population; Moderate-risk Population; Average-risk Population
  • 3) By End User: Hospitals; Diagnostic Centres; Cancer Institutes; Research Laboratories
  • Subsegments:
  • 1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test; Gene Expression Profiling Test; Circulating Tumor Dna (Ctdna) Test; Proteomic Biomarker Test
  • 2) By Imaging Test: Mammography; Magnetic Resonance Imaging Screening Test; Molecular Breast Imaging Test; Positron Emission Mammography; Ultrasound
  • 3) By Genetic Test: Fluorescence In Situ Hybridization; Her Gene Test
  • 4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test; Ki-67 Proliferation Marker Test; Progesterone Receptor (Pr) Test; Her2 Or Neu Test
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH; Fujifilm Corporation; Koninklijke Philips NV; GE HealthCare Technologies Inc.; Quest Diagnostics Incorporated; Hologic Inc.; Hitachi High-Tech Corporation; Exact Sciences Corporation; Natera Inc.; Myriad Genetics Inc.; Canon Medical Systems Corporation; Provista Diagnostics Inc.; Niramai Health Analytix Pvt. Ltd.; Kheiron Medical Technologies Limited; UE LifeSciences Inc.; BD (Becton Dickinson and Company); Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Breast Cancer Screening Test Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Breast Cancer Screening Test Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Breast Cancer Screening Test Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Breast Cancer Screening Test Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Advanced Imaging-Based Screening Tests
    • 4.2.2 Rising Use Of Genetic And Molecular Diagnostics
    • 4.2.3 Growing Integration Of Ai In Image Interpretation
    • 4.2.4 Expansion Of Multi-Modal Screening Approaches
    • 4.2.5 Enhanced Focus On Early And Preventive Diagnostics

5. Breast Cancer Screening Test Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centres
  • 5.3 Cancer Institutes
  • 5.4 Research Laboratories
  • 5.5 Specialty Oncology Clinics

6. Breast Cancer Screening Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Breast Cancer Screening Test Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Breast Cancer Screening Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Breast Cancer Screening Test Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Breast Cancer Screening Test Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Breast Cancer Screening Test Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Breast Cancer Screening Test Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Breast Cancer Screening Test Market Segmentation

  • 9.1. Global Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test
  • 9.2. Global Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High-risk Population, Moderate-risk Population, Average-risk Population
  • 9.3. Global Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Centres, Cancer Institutes, Research Laboratories
  • 9.4. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Blood Marker Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Circulating Tumor Cells (Ctcs) Test, Gene Expression Profiling Test, Circulating Tumor Dna (Ctdna) Test, Proteomic Biomarker Test
  • 9.5. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mammography, Magnetic Resonance Imaging Screening Test, Molecular Breast Imaging Test, Positron Emission Mammography, Ultrasound
  • 9.6. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescence In Situ Hybridization, Her Gene Test
  • 9.7. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Immunohistochemistry Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Estrogen Receptor (Er) Test, Ki-67 Proliferation Marker Test, Progesterone Receptor (Pr) Test, Her2 Or Neu Test

10. Breast Cancer Screening Test Market Regional And Country Analysis

  • 10.1. Global Breast Cancer Screening Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Breast Cancer Screening Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Breast Cancer Screening Test Market

  • 11.1. Asia-Pacific Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Breast Cancer Screening Test Market

  • 12.1. China Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Breast Cancer Screening Test Market

  • 13.1. India Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Breast Cancer Screening Test Market

  • 14.1. Japan Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Breast Cancer Screening Test Market

  • 15.1. Australia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Breast Cancer Screening Test Market

  • 16.1. Indonesia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Breast Cancer Screening Test Market

  • 17.1. South Korea Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Breast Cancer Screening Test Market

  • 18.1. Taiwan Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Breast Cancer Screening Test Market

  • 19.1. South East Asia Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Breast Cancer Screening Test Market

  • 20.1. Western Europe Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Breast Cancer Screening Test Market

  • 21.1. UK Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Breast Cancer Screening Test Market

  • 22.1. Germany Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Breast Cancer Screening Test Market

  • 23.1. France Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Breast Cancer Screening Test Market

  • 24.1. Italy Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Breast Cancer Screening Test Market

  • 25.1. Spain Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Breast Cancer Screening Test Market

  • 26.1. Eastern Europe Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Breast Cancer Screening Test Market

  • 27.1. Russia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Breast Cancer Screening Test Market

  • 28.1. North America Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Breast Cancer Screening Test Market

  • 29.1. USA Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Breast Cancer Screening Test Market

  • 30.1. Canada Breast Cancer Screening Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Breast Cancer Screening Test Market

  • 31.1. South America Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Breast Cancer Screening Test Market

  • 32.1. Brazil Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Breast Cancer Screening Test Market

  • 33.1. Middle East Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Breast Cancer Screening Test Market

  • 34.1. Africa Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Breast Cancer Screening Test Market Regulatory and Investment Landscape

36. Breast Cancer Screening Test Market Competitive Landscape And Company Profiles

  • 36.1. Breast Cancer Screening Test Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Breast Cancer Screening Test Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Breast Cancer Screening Test Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Breast Cancer Screening Test Market Other Major And Innovative Companies

  • Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD (Becton, Dickinson and Company), Agilent Technologies Inc.

38. Global Breast Cancer Screening Test Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Breast Cancer Screening Test Market

40. Breast Cancer Screening Test Market High Potential Countries, Segments and Strategies

  • 40.1 Breast Cancer Screening Test Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Breast Cancer Screening Test Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Breast Cancer Screening Test Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer